Wenqiao Yu
Overview
Explore the profile of Wenqiao Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li H, Ding P, Nan Y, Wu Z, Hua N, Luo L, et al.
J Intensive Care
. 2025 Mar;
13(1):12.
PMID: 40065471
Background: Sepsis is a critical condition associated with high morbidity and mortality, emphasizing the need for reliable biomarkers for its diagnosis and prognosis. This study uses advanced immunological techniques to...
2.
Li H, Mao X, Wu Z, Yu W
Br J Hosp Med (Lond)
. 2024 Dec;
85(11):1-12.
PMID: 39618230
is an obligate intracellular bacterium that primarily infects birds, but can cause respiratory infections in humans. Clinical evidence supporting the use of omadacycline for the treatment of pneumonia remains limited;...
3.
Chen N, Yu X, Li L, Yang P, Dong R, Huang Y, et al.
Infect Drug Resist
. 2024 Sep;
17:4055-4065.
PMID: 39309067
Background: The population pharmacokinetics of nirmatrelvir/ritonavir (NIR/RIT) has not yet been described for critically ill adult patient. Purpose: This was a prospective observational population pharmacokinetic study of nirmatrelvir/ritonavir (NIR/RIT) in...
4.
Chen S, Zhang C, Wang Z, Zhang J, Yu W, Wang Y, et al.
J Zhejiang Univ Sci B
. 2024 Aug;
25(8):711-718.
PMID: 39155783
This study presents a multi-center clinical data management platform that facilitates unified and structured management of real-world data and serves as an ideal tool to enhance the quality and progress...
5.
Ding P, Li H, Nan Y, Liu C, Wang G, Cai H, et al.
Int J Antimicrob Agents
. 2024 Aug;
64(4):107293.
PMID: 39094752
Purpose: The incidence of pneumonia caused by multidrug-resistant gram-negative bacteria (MDR GNB) is increasing, which imposes significant burden on public health. Inhalation combined with intravenous polymyxins has emerged as a...
6.
Wu Z, Yao Y, Li X, Cai H, Wang G, Yu W, et al.
Infect Dis (Lond)
. 2024 May;
56(10):830-841.
PMID: 38753988
Background: There is a critical need for a rapid and sensitive pathogen detection method for septic patients. This study aimed to investigate the diagnostic efficacy of Digital droplet polymerase chain...
7.
Dong R, Huang Y, Ling X, Li L, Yu W, Jiang S
Int J Antimicrob Agents
. 2023 Oct;
63(1):106997.
PMID: 37848106
Objectives: Nirmatrelvir/ritonavir is a highly efficacious agent against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Although dose adjustment is recommended in patients with renal impairment according to the package...
8.
Fu S, Yu W, Fu Q, Xu Z, Zhang S, Liang T
BMC Surg
. 2023 Sep;
23(1):274.
PMID: 37700315
Background: Septic shock is one of the leading causes of mortality in intensive care units. This retrospective study was carried out to evaluate the association of clinical available factors with...
9.
Li H, Yu W, Wang G, Cai H
Front Med (Lausanne)
. 2022 Jul;
9:913364.
PMID: 35872774
Introduction: Post-neurosurgical central nervous system (CNS) infection caused by multidrug-resistant (MDR)/extensively drug-resistant (XDR) Gram-negative bacteria remains a major clinical challenge. This study describes our experience of treating such patients with...
10.
Fu Q, Yu W, Fu S, Xu Z, Zhang S
Mol Immunol
. 2022 Apr;
146:18-26.
PMID: 35421737
Background: Acute kidney injury caused by sepsis has become a hotspot of scientific research in recent years. Since the kidney is the most abundant of all organs with vascular endothelium,...